MedPath

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Recruiting
Conditions
Invasive Breast Cancer Early Stages
Registration Number
NCT03390894
Lead Sponsor
Spanish Breast Cancer Research Group
Brief Summary

This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group.

Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years

Detailed Description

One consequence of the improvement in survival rates of certain tumors such as breast cancer is the increase in the number of patients available for long-term follow-up in randomized controlled clinical trials. This long follow-up allows an additional long-term evaluation of the efficacy, as well as of the sequelae related to the treatments that may occur beyond the time of the primary analysis.

The target population of the study are all patients who were included in neoadjuvant and adjuvant clinical trials of GEICAM performed by the goup since 1998 in the medical oncology units of the participating sites, ensuring a follow-up of patients of approximately 30 years. This will allow to describe the long-term evolution of the patients with invasive breast cancer in early stages.

The information obtained will be very useful to professionals involved in the diagnosis, treatment and monitoring of breast cancer, hospital managers, patients with this condition and society in general. This study provides data of great interest for the estimation of long-term disease requirements.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
8000
Inclusion Criteria
  • Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected.
  • Patients whose death or contact loss has not been previously collected in the databases of the original studies.
Exclusion Criteria
  • Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Event Free Survival (EvFS) in neoadjuvant studies.Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.

The EvFS, is defined as the time from the randomization of the patients in the studies of origin, to the date of one of the following events:

* Disease progression during neoadjuvant treatment.

* Disease relapse (local, regional or distant) after curative surgery.

* Second primary tumors

* Death due to any cause.

Disease Free Survival (DFS) in adjuvant studies.Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.

DFS is defined as the time from the date of randomization of patients in the studies of origin, to the date of one of the following events:

* Disease relapse (local, regional or distant) after curative surgery.

* Second primary tumors

* Death due to any cause.

Secondary Outcome Measures
NameTimeMethod
Overall Survival (OS).Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.

Overall Survival (OS) defined as the time from the date of study enrolment to the date of death from any cause.

Trial Locations

Locations (73)

Centro Oncológico de Galicia

🇪🇸

A Coruña, Spain

Complejo Hospitalario Universitario de Albacete

🇪🇸

Albacete, Spain

Hospital Infanta Cristina

🇪🇸

Badajoz, Spain

Hospital General Universitario de Elche

🇪🇸

Alicante, Spain

Hospital General Universitario de Alicante

🇪🇸

Alicante, Spain

Hospital Universitario Mutua Terrassa

🇪🇸

Barcelona, Spain

Hospital Virgen De Los Lirios

🇪🇸

Alicante, Spain

Complejo Especialidades de Jerez de la Frontera

🇪🇸

Cadiz, Spain

Hospital Universitario Puerta del Mar

🇪🇸

Cádiz, Spain

Hospital Universitario Lucus Augusti

🇪🇸

Lugo, Spain

Hospital Virgen De La Luz

🇪🇸

Cuenca, Spain

Hospital Universitari Germans Trias i Pujol

🇪🇸

Badalona, Spain

Complejo Hospitalario A Coruña

🇪🇸

A Coruña, Spain

Hospital San Agustín Avilés

🇪🇸

Avilés, Asturias, Spain

Consorci Sanitari de Terrassa

🇪🇸

Barcelona, Spain

Hospital General Universitario de Elda

🇪🇸

Alicante, Spain

Hospital Clinic i Provincial

🇪🇸

Barcelona, Spain

Hospital Arnau Vilanova

🇪🇸

Valencia, Spain

Complejo Hospitalario de Castellón

🇪🇸

Castelló, Spain

Complejo Hospitalario Universitario de Gran Canaria Dr. Negrín

🇪🇸

Palmas de Gran Canaria, Spain

Hospital Álvaro Cunqueiro

🇪🇸

Pontevedra, Spain

Hospital Clínico Universitario de Valencia

🇪🇸

Valencia, Spain

Hospital General Universitario de Valencia

🇪🇸

Valencia, Spain

Hospital Clínico Universitario de Zaragoza Lozano Blesa

🇪🇸

Zaragoza, Spain

Hospital Universitario de Canarias

🇪🇸

La Laguna, Tenerife, Spain

Hospital Universitario de Burgos

🇪🇸

Burgos, Spain

Hospital Universitario de Cruces

🇪🇸

Donostia, Spain

Hospital Universitario Virgen De Las Nieves

🇪🇸

Granada, Spain

Hospital Universitario de Salamanca

🇪🇸

Salamanca, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Hospital Universitario Reina Sofía

🇪🇸

Córdoba, Spain

Hospital Universitario Donostia

🇪🇸

Donostia, Spain

Onkologikoa

🇪🇸

Donostia, Spain

Instituto Catalán de Oncología Gerona Hospital Dr. Josep Trueta

🇪🇸

Gerona, Spain

Hospital Universitario de Guadalajara

🇪🇸

Guadalajara, Spain

Complejo Hospitalario de Especialidades Juan Ramón Jiménez

🇪🇸

Huelva, Spain

Hospital Universitario San Cecilio

🇪🇸

Granada, Spain

Complejo Hospitalario de Jaén

🇪🇸

Jaén, Spain

Hospital de León

🇪🇸

León, Spain

Hospital Madrid Montepricipe

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Universitario La Princesa

🇪🇸

Madrid, Spain

Hospital Universitario Ramón y Cajal

🇪🇸

Madrid, Spain

Hospital Universitario Severo Ochoa

🇪🇸

Madrid, Spain

MD Anderson Cancer Center

🇪🇸

Madrid, Spain

ALTHAIA Xarxa Asistencial Universitària Manresa

🇪🇸

Manresa, Spain

Hospital Clínico Universitario Virgen de la Arrixaca

🇪🇸

Murcia, Spain

Hospital santa María Naí

🇪🇸

Orense, Spain

Hospital Universitario Virgen de la Victoria

🇪🇸

Málaga, Spain

Hospital Regional de Málaga Carlos Haya

🇪🇸

Málaga, Spain

Complejo Hospitalario de Palencia

🇪🇸

Palencia, Spain

Corporación Sanitaria Parc Taulí

🇪🇸

Sabadell, Spain

Hospital Universitario de Valme

🇪🇸

Sevilla, Spain

Hospital Nuestra Señora De La Candelaria

🇪🇸

Tenerife, Spain

Hospital Universitario Sant Joan De Reus

🇪🇸

Tarragona, Spain

Fundación Instituto Valenciano de Oncología

🇪🇸

Valencia, Spain

Hospital Virgen de la Salud

🇪🇸

Toledo, Spain

Hospital de Txagorritxu

🇪🇸

Vitoria, Spain

Hospital de Sagunto

🇪🇸

Valencia, Spain

Hospital Universitari i Politécnic La Fe

🇪🇸

Valencia, Spain

Hospital Universitario Dr. Peset Aleixandre

🇪🇸

Valencia, Spain

Hospital Universitario Miguel Servet

🇪🇸

Zaragoza, Spain

Hopsital Clínico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital general Universitario Gregorio Marañón

🇪🇸

Madrid, Spain

Hospital General Universitario José María Morales Meseguer

🇪🇸

Murcia, Spain

Hospital Universitario Fundación Alcorcón

🇪🇸

Madrid, Spain

Hospital Universitario de Basurto

🇪🇸

Bilbao, Spain

Hospital de Mostoles

🇪🇸

Madrid, Spain

Hospital Universitario Fuenlabrada

🇪🇸

Madrid, Spain

Instituto Catalán Oncología Barcelona Hospital Duran I Reynalds

🇪🇸

Barcelona, Spain

Complejo Hospitalario de Navarra

🇪🇸

Pamplona, Navarra, Spain

© Copyright 2025. All Rights Reserved by MedPath